Shares of Usana Health Sciences (USNA), a leading manufacturer of nutritional products and supplements, surged 6.12% on Tuesday, October 23, 2024, following an impressive third-quarter earnings report released the previous day.
Despite missing revenue expectations, Usana posted better-than-anticipated earnings per share for the quarter ended September 30, 2024. The company reported adjusted EPS of $0.56, surpassing Wall Street's consensus estimate of $0.49 and marking a slight improvement over the same period last year.
While Usana's revenue declined 6.2% year-over-year to $200.22 million, falling short of analysts' projections of $205.77 million, the company's strong earnings performance appeared to outweigh concerns over the top-line miss. Investors responded positively to the earnings beat, driving Usana's stock price higher.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
If the download button clicks without skipping, click on the top right menu and select "Open in Browser."